World's Best Scientists 2026 revealed!
Hans-Konrad Müller-Hermelink

Hans-Konrad Müller-Hermelink

D-Index & Metrics

Medicine

D-Index
116
Citations
64011
World Ranking
4291
National Ranking
233

Research.com Recognitions

  • 1994 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Pathology and Forensic Medicine

Overview

Hans-Konrad Müller-Hermelink is affiliated with the University of Würzburg in Germany. Their academic profile reflects contributions recognized within the fields of pathology and forensic medicine, as indicated by their membership award from the German National Academy of Sciences Leopoldina in 1994, under the category of Pathology and Forensic Medicine.

Although specific recent papers, co-authors, publication venues, book publications, and detailed research topics are not listed, the noted award emphasizes an established role within medical research, particularly related to pathological and forensic investigations.

Their career involves scientific work primarily rooted in pathology, which encompasses the study and diagnosis of disease, and in forensic medicine, highlighting applications of medical knowledge to legal investigations. These areas imply expertise in analyzing disease processes, as well as contributing insights relevant to legal and investigative contexts.

The professional recognition by a national scientific academy suggests a significant standing in the scientific community relevant to their specialties. This affiliation typically denotes engagement with academic research, potentially including clinical studies and analysis, although direct evidence of publications or collaborative networks is not provided.

Best Publications

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    James O. Armitage

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Christian Steidl;Tang Lee;Sohrab P. Shah;Pedro Farinha

  • A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

    Michael Hummel;Stefan Bentink;Hilmar Berger;Wolfram Klapper

  • The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997

    N. L. Harris;E. S. Jaffe;J. Diebold;G. Flandrin

  • Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

    Volker Diehl;Jeremy Franklin;Michael Pfreundschuh;Bernd Lathan

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

  • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

    Georg Lenz;R. Eric Davis;Vu N. Ngo;Lloyd Lam

  • Cyclin D1-negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling

    Kai Fu;Dennis D. Weisenburger;Timothy Charles Greiner;Sandeep Dave

  • Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

    Andreas Engert;Volker Diehl;Jeremy Franklin;Andreas Lohri

  • Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group

    Andreas Engert;Petra Schiller;Andreas Josting;Richard Herrmann

  • Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project

    T. Rüdiger;D. D. Weisenburger;J. R. Anderson;J. O. Armitage

  • The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

    N L Harris;E S Jaffe;J Diebold;G Flandrin

  • The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

    N L Harris;E S Jaffe;J Diebold;G Flandrin

  • Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study

    Peter Reimer;Thomas Rüdiger;Eva Geissinger;Florian Weissinger

Frequent Co-Authors

Andreas Rosenwald
Andreas Rosenwald University of Würzburg
German Ott
German Ott Robert Bosch (Germany)
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Elias Campo
Elias Campo University of Barcelona
Socrates J. Tzartos
Socrates J. Tzartos Institut Pasteur
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Jan Delabie
Jan Delabie University Health Network
Nancy Lee Harris
Nancy Lee Harris World Resources Institute
George W. Wright
George W. Wright National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if traditional medical school is right for you? There are several flexible online degree options to consider that open doors to rewarding careers in healthcare. For those leaning towards healthcare leadership, cahme accredited online healthcare administration programs offer the chance to build management skills and advance in hospital and clinical settings, all from home.

Nursing is a popular alternative. If you’re already a registered nurse, you can upgrade your qualifications through an rn to bsn online without clinicals program, making it accessible and convenient for working professionals. For nurses seeking the highest clinical expertise, pursuing a Doctor of Nursing Practice (DNP) online can accelerate your progress. Some of the fastest online dnp programs let you earn your doctorate in less time.

Additionally, if you prefer a more academic or leadership role, check out online dnp programs without clinicals for streamlined study options. These pathways can help you launch or advance a healthcare career, even if you aren't pursuing a traditional MD.

Best Scientists Citing Hans-Konrad Müller-Hermelink

Trending Scientists